POSSIBILITIES OF USING PROBIOTICS FOR HELICOBACTER PYLORI ERADICATION: MAASTRICHT V CONSENSUS CONFERENCE RECOMMENDATIONS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The new European consensus for the management of patients with Helicobacter pylori (Hp)-associated diseases draws attention to the fact that the stomach has a large number of microorganisms that can influence the development of abnormalities. The use of probiotics contributes to a reduction in the incidence of side effects and enhances the effectiveness of Hp eradication.

Full Text

Restricted Access

About the authors

V. Tsukanov

Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch of the Russian Academy of Sciences

Email: gastro@impn.ru
Professor

E. Kasparov

Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch of the Russian Academy of Sciences

Email: gastro@impn.ru
Professor

A. Vasyutin

Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch of the Russian Academy of Sciences

Email: gastro@impn.ru
Candidate of Medical Sciences

Yu. Tonkikh

Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch of the Russian Academy of Sciences

Email: gastro@impn.ru
Candidate of Medical Sciences

References

  1. Malfertheiner P., Megraud F., O'Morain C.A. et al. Management of Helicobacter pylori infection-the Maastricht V / Florence Consensus Report // Gut. - 2017; 66 (1): 6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.
  2. Bik E., Eckburg P., Gill S. et al. Molecular analysis of the bacterial microbiota in the human stomach // Proc. Natl. Acad. Sci. USA. - 2006; 103 (3): 732-7.
  3. Cao L., Yu J. Effect of Helicobacter pylori Infection on the Composition of Gastric Microbiota in the Development of Gastric Cancer // Gastrointest. Tumors. -2015; 2 (1): 14-25.
  4. Khosravi Y., Dieye Y., Poh B. et al. Culturable bacterial microbiota of the stomach of Helicobacter pylori positive and negative gastric disease patients // Sci. World J. - 2014; 2014: 610421.
  5. Sheh A., Fox J. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis // Gut Microbes. - 2013; 4 (6): 505-31.
  6. Буторин Н.Н., Бичурина Т.Б., Цуканов В.В. и др. Распространенность и клинические аспекты пищевода Барретта у населения Восточной Сибири // Тер. арх. - 2013; 1: 62-5.
  7. Цуканов В.В., Третьякова О.В., Амельчугова О.С. и др. Распространенность атрофического гастрита тела желудка у населения г. Красноярска старше 45 лет // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2012; 4: 27-31.
  8. Цуканов В.В., Селиверстова Е.В., Догадин С.А. Показатели липидного состава сыворотки крови и желчи при заболеваниях желчевыводящих путей у больных сахарным диабетом // Тер. арх. - 2005; 2: 15-8.
  9. Агеева Е.С., Штыгашева О.В., Цуканов В.В. и др. Иммунологические особенности течения гастродуоденальной патологии у жителей Хакасии // Иммунология. - 2009; 3: 162-4.
  10. Агеева Е.С., Штыгашева О.В., Рязанцева Н.В. и др. Молекулярногенетические факторы, влияющие на исход инфицирования Helicobacter pylori у жителей Республики Хакасия // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2010; 4: 16-21.
  11. Dicksved J., Lindberg M., Rosenquist M. et al. Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls // J. Med. Microbiol. - 2009; 58 (Pt. 4): 509-16.
  12. Eun C., Kim B., Han D. et al. Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal metaplasia, and gastric cancer using pyrosequencing methods // Helicobacter. - 2014; 19 (6): 407-16.
  13. Lofgren J., Whary M., Ge Z. et al. Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia // Gastroenterology. - 2011; 140 (1): 210-20.
  14. Jernberg C., Löfmark S., Edlund C. et al. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota // ISME J. - 2007; 1 (1): 56-66.
  15. Ladirat S., Schols H., Nauta A. et al. High-throughput analysis of the impact of antibiotics on the human intestinal microbiota composition // J. Microbiol. Methods. - 2013; 92 (3): 387-97.
  16. Engelbrektson A., Korzenik J., Pittler A. et al. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy // J. Med. Microbiol. - 2009; 58 (Pt. 5): 663-70.
  17. Lv Z., Wang B., Zhou X. et al. Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: A metaanalysis // Exp. Ther. Med. - 2015; 9 (3): 707-16.
  18. Szajewska H., Horvath A., Piwowarczyk A. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment // Aliment. Pharmacol. Ther. - 2010; 32 (9): 1069-79.
  19. Zhang M., Qian W., Qin Y. et al. Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis // World J. Gastroenterol. - 2015; 21 (14): 4345-57.
  20. Marshall B., Warren J. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration // Lancet. - 1984; 1 (8390): 1311-5.
  21. Цуканов В.В., Каспаров Э.В., Васютин А.В. и др. Микробиом желудка: развитие революции // Фарматека. - 2016: 15: 78-81.
  22. Sugano K., Tack J., Kuipers E. et al. Kyoto global consensus report on Helicobacter pylori gastritis // Gut. - 2015; 64 (9): 1353-67.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies